Condition
Orbital Neoplasms
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06791226Not ApplicableRecruitingPrimary
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT05645341CompletedPrimary
Artificial Intelligence-assisted Screening of Malignant Pigmented Tumors on the Ocular Surface
NCT06336499CompletedPrimary
Risk Stratification of Orbital Tumors Based on MRl and Artificial Intelligence
NCT05438784Not ApplicableUnknown
Application of CAD-CAM Technology in Orbital Bone Reconstruction
Showing all 4 trials